Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2016

01-12-2016 | Case Report

Clinical Significance of Rare Maternal Anti Jka Antibody

Authors: Kshitija Mittal, Tanvi Sood, Naveen Bansal, Ravneet Kaur Bedi, Paramjit Kaur, Gagandeep Kaur

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2016

Login to get access

Abstract

We hereby report a rare case of HDFN because of antibody to Kidd (Jk) blood group system—anti Jka. An EDTA sample of a baby along with mother’s sample was received in the Department for Direct Antiglobulin Test (DAT) alongwith blood requisition for double volume exchange transfusion. On blood grouping, baby’s and mother’s blood group was found to be B Rh D positive. DAT with polyspecific anti human globulin (AHG) was positive. Screening of mother’s serum for irregular antibodies showed anti-Jka antibody. AHG phase titers using tube technique were 1:64. Mother was found to be Jka antigen negative; father and neonate were found to be Jka antigenpositive. Antibody was observed to be of IgG type on Dithiothreitol treatment. Baby had total serum bilirubin of 20.5 mg/dl on day 3 of life and phototherapy was started. Exchange transfusion was not required in the baby. The present case emphasises the significance of minor blood group antigens other than Rh blood group system as a cause of HDFN. Although HDFN due to Jk antibodies is rare, however, the clinician must be aware of the occurrence of these antibodies as they can lead to severe HDFN and persistent anemia in the infant.
Literature
1.
go back to reference Paparizos LF, Valsami S, Bournas N, Tsantes A, Grapsas P, Mantzios G, Travlou A, Politou M (2013) Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme. Transfus Med 23:254–259CrossRef Paparizos LF, Valsami S, Bournas N, Tsantes A, Grapsas P, Mantzios G, Travlou A, Politou M (2013) Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme. Transfus Med 23:254–259CrossRef
2.
go back to reference Daniels G (2002) The human blood groups, 2nd edn. Blackwell Science, OxfordCrossRef Daniels G (2002) The human blood groups, 2nd edn. Blackwell Science, OxfordCrossRef
3.
go back to reference Thakral B, Malhotra S, Saluja K, Kumar P, Marwaha N (2010) Hemolytic disease of newborn due to anti-Jkb in a woman with high risk pregnancy. Transfus Apher Sci 43:41–43CrossRefPubMed Thakral B, Malhotra S, Saluja K, Kumar P, Marwaha N (2010) Hemolytic disease of newborn due to anti-Jkb in a woman with high risk pregnancy. Transfus Apher Sci 43:41–43CrossRefPubMed
4.
go back to reference Leger RM, Colhaun L (2005) Other major blood group systems. In: Harmening DM (ed) Modern blood banking and transfusion practices, 5th edn. F.A. Davis Company, Philadelphia, pp 182–183 Leger RM, Colhaun L (2005) Other major blood group systems. In: Harmening DM (ed) Modern blood banking and transfusion practices, 5th edn. F.A. Davis Company, Philadelphia, pp 182–183
5.
go back to reference Allen FH, Diamond LK, Niedziela B (1951) A new blood group antigen. Nature 167:482CrossRef Allen FH, Diamond LK, Niedziela B (1951) A new blood group antigen. Nature 167:482CrossRef
6.
go back to reference Coleman WB, Tsongalis GJ (2006) Molecular diagnostics: for the clinical laboratorian. In: Hessner MJ, Curtis BR (eds) Prenatal genotyping, 2nd edn. Human Press, Totowa, p 334 Coleman WB, Tsongalis GJ (2006) Molecular diagnostics: for the clinical laboratorian. In: Hessner MJ, Curtis BR (eds) Prenatal genotyping, 2nd edn. Human Press, Totowa, p 334
7.
go back to reference Matson GA, Swanson J, Tobin JD (1959) Severe haemolytic disease of the newborn caused by anti-Jka. VoxSanguinis 4:144–147 Matson GA, Swanson J, Tobin JD (1959) Severe haemolytic disease of the newborn caused by anti-Jka. VoxSanguinis 4:144–147
8.
go back to reference Baek EJ, Park SC, Kwon YH, Kim CR (2013) Hemolytic disease of newborn due to anti-Jka and the duration of antibody persistence. J Pediatr Child Health 49:E101–E102CrossRef Baek EJ, Park SC, Kwon YH, Kim CR (2013) Hemolytic disease of newborn due to anti-Jka and the duration of antibody persistence. J Pediatr Child Health 49:E101–E102CrossRef
9.
go back to reference Ramsey G, Larson P (1988) Loss of red cell antibodies over time. Transfusion 28:102–165CrossRef Ramsey G, Larson P (1988) Loss of red cell antibodies over time. Transfusion 28:102–165CrossRef
Metadata
Title
Clinical Significance of Rare Maternal Anti Jka Antibody
Authors
Kshitija Mittal
Tanvi Sood
Naveen Bansal
Ravneet Kaur Bedi
Paramjit Kaur
Gagandeep Kaur
Publication date
01-12-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0688-5

Other articles of this Issue 4/2016

Indian Journal of Hematology and Blood Transfusion 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine